Cardiff Oncology, Inc. (CRDF) › Total AssetsCardiff Oncology, Inc. (CRDF) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $1.04M2012: $11.67M2013: $27.16M2014: $28.90M2015: $71.45M2016: $43.95M2017: $12.28M2018: $14.17M2019: $13.09M2020: $134.73M2021: $149.54M2022: $116.19M2023: $81.64M2024: $97.19M2025: $61.88M$61.88M2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$61.88M-36.3%2024$97.19M+19.1%2023$81.64M-29.7%2022$116.19M-22.3%2021$149.54M+11.0%2020$134.73M+929.5%2019$13.09M-7.7%2018$14.17M+15.4%2017$12.28M-72.0%2016$43.95M-38.5%2015$71.45M+147.2%2014$28.90M+6.4%2013$27.16M+132.8%2012$11.67M+1022.4%2011$1.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share